Ackermans & Van Haaren NV

Ackermans & Van Haaren NV

ACKB · BR · Industrials / Engineering & Construction

262.6EUR+2.40 (+0.92%)

Price History

Full chart

Market Stats

Previous Close260.2
Open262
Day Range262 – 262.6
52-Week Range204.71 – 295.17
Volume1.47K
Market Cap8.58B
P/E (TTM)13.06
Forward P/E14.06
EPS20.11
Dividend Yield1.77%
Beta0.75
50-Day Avg267.44
200-Day Avg268.13

About

Ackermans & Van Haaren NV engages in marine engineering and contracting, private banking, real estate, energy and resources, and growth capital businesses worldwide. The Marine Engineering & Contracting segment engages in the marine construction activities, including dredging and civil works on water, as well as offshore activities in the areas of renewable energy, oil and gas, soil and sludge remediation, and aggregate and mineral extraction; real estate development, multitechnics, and construction and renovation activities; and development of port projects and related industrial zones, as well as offshore wind farms. The Private Banking segment offers discretionary asset management services for private clients; and specialized advisory banking services for entrepreneurs and liberal professionals, as well as financing and financial leasing services for cars, equipment, charging stations, and bicycles. The Real Estate segment develops mixed real estate projects, including redevelopment of iconic buildings and new constructions and residential, retail, and office properties. The Energy & Resources segment produces crude palm oil and bananas; offers hybrid palm oil seeds; and manufactures cement. The AvH & Growth Capital segment provides engineering and solutions in production process automation; validation and compliance services; compact biogas installation; specialty chemicals; and logistics services for rail, port and road transport, and intermodal transport, and warehousing. It also offers crop and food protection products and deals and leases commercial vehicles, as well as distributes aftermarket products. The company also develops medical devices and medicines for the treatment of cancer and genetic diseases. Ackermans & Van Haaren NV was founded in 1876 and is based in Antwerp, Belgium.

Company Details

  • SectorIndustrials
  • IndustryEngineering & Construction
  • CEOMr. Piet Dejonghe
  • Employees24.93K
  • HeadquartersBegijnenvest 113, Antwerp, Belgium, 2000, Belgium
  • Websitehttps://www.avh.be

Leadership

  • Mr. Piet DejongheCo-CEO & Co-Chairman of the Executive Committee · b. 1966
  • Mr. John-Eric Fernand Pascal Cesar BertrandCo-CEO & Co-Chairman of the Executive Committee · b. 1977
  • Mr. Tom BamelisCFO, Financial Director & Member of the Executive Committee · b. 1966
  • Mr. Pieter BevernageSecretary General, General Counsel & Member of the Executive Committee · b. 1968
  • Mr. Koen JanssenMember of the Executive Committee · b. 1970
  • Mr. Andre-Xavier P. L. M. CooremanMember of the Executive Committee · b. 1964
  • Ms. An HerremansMember of the Executive Committee · b. 1982
  • Mr. Chris Van RaemdonckCommunication & Investor Relations Manager
  • Ms. Hilde HaemsChief Human Capital Officer
  • Mr. Bart VercauterenHead of ESG

Financials

Income Statement

Line item2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.22M2.73M3.41M3.12M1.83B349.74M372.03M363.97M409.96M393.96M338.70M389.20M443.36M526.03M4.16B4.02B3.66B3.96B4.47B4.27B3.91B4.31B4.40B5.22B6.04B5.96B
Cost of Revenue----153.63M135.71M160.49M103.81M97.97M127.00M86.17M109.61M203.56M151.82M2.25B2.00B1.74B1.98B2.29B3.36B3.70B3.90B4.03B3.34B3.95B5.14B
Gross Profit----1.67B214.02M211.55M260.17M311.99M266.96M252.54M279.58M239.81M374.20M1.91B2.02B1.91B1.98B2.18B913.71M210.88M410.19M372.18M1.88B2.09B819.53M
Operating Income----76.16M31.03M38.37M68.15M16.00M51.79M65.38M55.59M62.15M143.82M363.71M377.09M373.89M348.79M409.97M377.42M209.30M409.64M363.77M428.13M478.36M813.72M
EBITDA----248.79M340.61M357.77M316.39M301.73M249.60M283.50M247.88M164.28M155.45M620.17M644.01M698.13M779.84M781.30M859.80M558.16M975.91M1.06B1.05B1.25B1.35B
Net Income-91.88M14.80M55.07M134.79M278.99M307.60M303.39M154.65M145.78M160.80M214.38M167.47M293.90M215.13M284.08M224.24M302.53M289.64M394.90M229.79M406.81M708.65M399.19M459.87M592.55M
R&D-------------65.00K---70.00K573.00K771.00K663.00K30.00K108.00K509.00K--
Interest Expense000078.67M70.88M74.62M23.36M24.29M14.75M69.83M21.98M13.30M11.97M44.18M147.59M123.04M138.71M124.15M96.18M62.29M56.45M57.41M150.91M207.70M180.63M

Balance Sheet

Line item2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets859.58M942.74M1.20B985.29M4.48B4.21B4.72B4.89B5.22B5.32B5.60B6.52B6.76B11.03B11.46B12.25B12.88B13.47B14.17B15.36B16.29B17.24B17.68B19.02B20.29B21.26B
Total Liabilities249.65M271.93M344.22M240.66M3.36B2.90B2.92B2.47B2.88B3.30B3.45B4.15B4.25B7.75B7.99B8.44B8.96B9.27B9.81B10.67B11.50B12.01B11.68B12.64B13.48B13.94B
Total Equity495.28M562.65M562.97M599.05M814.84M1.12B1.42B1.58B1.52B2.02B1.71B1.88B2.01B2.25B2.37B2.61B2.78B2.97B3.18B3.46B3.56B3.96B4.63B4.91B5.28B5.70B
Cash1.97M1.39M5.03M1.19M183.18M351.09M214.78M33.07M186.63M189.36M168.56M1.24B158.21M767.01M922.23M704.99M754.32M637.03M513.59M887.99M842.41M883.73M1.16B989.81M3.29B1.46B
Total Debt----2.69B2.62B2.69B477.85M585.09M23.91M3.09B3.14B4.04B5.68B5.65B5.95B6.41B6.73B7.23B8.26B9.04B9.42B8.96B9.67B9.95B10.62B
Net Debt----2.50B2.27B2.48B444.78M398.47M-165.46M2.92B1.90B3.88B4.91B4.73B5.25B5.65B6.10B6.72B7.37B8.20B8.54B7.80B8.68B6.66B9.15B

Cash Flow

Line item2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-6.97M25.63M9.79M227.21M-122.63M69.67M156.89M238.84M53.42M-92.52M221.04M-184.60M401.24M555.03M414.00M658.21M548.58M428.48M566.31M567.26M769.48M705.12M651.19M1.41B742.66M
Investing Cash Flow8.93M7.83M61.88M32.45M-270.07M351.02M-127.35M-80.92M-171.55M-26.56M135.11M-70.36M13.79M-329.89M-167.30M-308.57M-466.49M-441.00M-565.21M-422.85M-413.11M-370.15M-41.04M-520.82M-529.13M-908.49M
Financing Cash Flow----121.12M-60.48M-90.62M-70.62M49.61M-143.11M-63.75M-38.51M43.24M33.11M-238.67M-353.59M-143.86M-202.57M15.38M229.44M-193.06M-359.41M-388.93M-302.18M-486.54M258.74M
Capital Expenditure334.00K229.00K914.00K90.00K13.64M10.15M21.00M22.91M74.26M22.45M8.76M44.95M23.76M39.88M219.76M308.17M217.14M491.84M505.92M503.15M236.60M319.02M514.53M433.99M310.16M469.43M
Free Cash Flow----213.56M-132.78M48.67M133.98M164.57M30.97M-101.28M176.09M-208.36M361.36M335.27M105.84M441.07M56.74M-77.44M63.16M330.67M450.46M190.59M217.20M1.10B273.23M
Dividends Paid21.34M17.47M19.74M19.74M18.10M21.69M29.99M17.96M13.47M13.05M47.70M71.09M54.35M55.35M56.36M60.36M64.98M67.64M73.02M76.74M76.81M77.89M91.08M102.51M111.30M124.43M

Earnings

Report DateFeb 28, 2014Aug 28, 2014Feb 27, 2015Aug 4, 2015Feb 26, 2016Aug 26, 2016Nov 22, 2016Feb 28, 2017Aug 31, 2017Feb 28, 2018May 28, 2018Aug 31, 2018Nov 19, 2018Feb 28, 2019May 23, 2019Aug 30, 2019Nov 22, 2019Feb 28, 2020May 27, 2020Aug 28, 2020Nov 23, 2020Feb 26, 2021May 20, 2021Aug 31, 2021Nov 23, 2021Feb 28, 2022May 19, 2022Aug 31, 2022Nov 23, 2022Feb 28, 2023May 17, 2023Aug 31, 2023Nov 23, 2023Feb 29, 2024May 23, 2024Aug 30, 2024Nov 22, 2024Mar 28, 2025Aug 29, 2025Dec 31, 2025Feb 26, 2027
EPS Estimate0.000.004.050.000.000.000.003.440.000.000.000.000.000.000.000.000.000.000.000.000.003.670.000.000.000.000.00-0.00-0.000.000.000.000.000.000.000.00---
EPS Actual0.000.000.000.000.000.000.004.204.015.080.003.360.005.350.006.410.005.480.001.700.006.930.005.000.0012.260.008.300.0021.280.000.000.000.000.000.000.007.938.349.76-
Surprise---100.00%----22.09%-------------88.83%-------------------
Timing---Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hours-----After-hours-Pre-market

Key Statistics & Ratios

Market Cap8.58B
Enterprise Value14.87B
Trailing P/E13.06
Forward P/E14.06
PEG Ratio5.74
Price / Sales1.44
Price / Book1.50
EPS20.11
Book Value180.58
Revenue (TTM)5.96B
Gross Profit (TTM)2.46B
EBITDA1.21B
Profit Margin11.06%
Operating Margin12.38%
Return on Equity11.83%
Return on Assets2.45%
Shares Outstanding32.66M
Shares Float21.61M
Beta0.75
Dividend Yield1.77%
Dividend Rate4.6
Payout Ratio47.14%

Dividends

20261×
4.60May 28, 2026
20251×
3.80May 29, 2025
20241×
3.40May 30, 2024
20231×
3.10May 29, 2023
20221×
2.75May 30, 2022
20211×
2.35May 27, 2021
20201×
2.32Nov 11, 2020
20191×
2.32Jun 3, 2019
20181×
2.20May 30, 2018
20171×
2.04May 29, 2017
20161×
1.96May 30, 2016
20151×
1.82Jun 1, 2015
20141×
1.70Jun 3, 2014
20131×
1.67May 29, 2013
20121×
1.64Jun 1, 2012
20111×
1.55May 27, 2011
20101×
1.44May 22, 2010
20091×
1.39May 29, 2009
20081×
1.39Jun 4, 2008
20071×
1.15Jun 1, 2007
20061×
0.90Jun 1, 2006
20051×
0.65Jun 1, 2005
20041×
0.54Jun 3, 2004
20031×
0.51Jun 5, 2003

Stock Splits

  • Jun 25, 199910:1